No Data
No Data
No Data
No Data
No Data
Krystal Biotech to Present at BofA Securities 2024 Health Care Conference
PITTSBURGH, May 08, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the
GlobeNewswire52minutes ago
Krystal Biotech Reveals Eye Treatment Vector at ARVO 2024
TipRanks18:14
Krystal Biotech Inc (KRYS) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ...
Yahoo FinanceMay 7 15:03
Krystal Biotech's Battle to Scale VYJUVEK Production Amid Regulatory Hurdles and Soaring Demand
TipRanksMay 7 14:00
Earnings Call Summary | Krystal Biotech(KRYS.US) Q1 2024 Earnings Conference
The following is a summary of the Krystal Biotech, Inc. (KRYS) Q1 2024 Earnings Call Transcript:Financial Performance:Krystal Biotech reported a strong Q1 2024 with net revenues of $45.3 million and g
Futu NewsMay 7 04:12 · Conference Call
Maintaining Buy Rating on Krystal Biotech: Strong VYJUVEK Sales and Promising Pipeline Despite EPS Miss
TipRanksMay 6 23:15
No Data
No Data